Simple assay for evaluation of Epstein-Barr virus specific cytotoxic T lymphocytes

Journal of Immunological Methods

Volumn 184, Issue 2, 1995, Pages 149-152

  Okano, Motohiko ^a   Purtilo, David T ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cyclosporin A; Epstein Barr virus specific cytotoxic T lymphocyte

Indexed keywords

CYCLOSPORIN A;

ARTICLE; ASSAY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

ANTIGEN PRESENTATION; CELL DIVISION; CELLS, CULTURED; CLONE CELLS; CYCLOSPORINE; HERPESVIRUS 4, HUMAN; HUMAN; METHODS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN HERPESVIRUS 4;

EID: 0029092837     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-1759(95)00082-L     Document Type: Article

References (9)

1. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines
2. Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in X-linked lymphoproliferative syndrome
3. Interferons and Epstein-Barr virus infection
4. Epstein-Barr virus and human diseases: recent advances in diagnosis
5. Adenovirus type-2 in a patient with lethal hemorrhagic colonic ulcers and chronic active Epstein-Barr virus infection
6. Long term observation in patients with Kawasaki syndrome and their relation to Epstein-Barr virus infection
7. Immunovirological studies of fatal infectious mononucleosis in a patients with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon-alpha
8. A simple method of estimating fitty per cent endpoints
9. Effect of in vitro cyclosporin A treatment on human natural and antibody-dependent cell-mediated cytotoxicity